Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Other Non-Current Assets (2011 - 2026)

Verastem (VSTM) posted quarterly Other Non-Current Assets of $241000.0 for Q1 2026, little changed year-over-year from $241000.0 in Q1 2025, and down 96.06% quarter-over-quarter from $6.1 million in Q4 2025.

Analysis

Verastem (VSTM) Other Non-Current Assets (2011 - 2026) Analysis & Trends

Verastem's Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $241000.0 for Q1 2026.

  • In Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $241000.0; the TTM figure through Mar 2026 stood at $241000.0 (changed 0.0% YoY), while the FY2025 annual figure was $6.1 million, up 24.76% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $241000.0, down from $6.1 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $6.1 million in Q4 2025, with the low at $36000.0 in Q1 2023.
  • The 5-year median for Other Non-Current Assets is $241000.0 (2022), against an average of $2.0 million.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets jumped 12608.33% in 2024, then tumbled 94.73% in 2025.
  • Verastem's Other Non-Current Assets stood at $241000.0 in 2022, then changed by 0.0% to $241000.0 in 2023, then soared by 1932.78% to $4.9 million in 2024, then advanced by 24.76% to $6.1 million in 2025, then sank by 96.06% to $241000.0 in 2026.
  • Business Quant data shows VSTM's Other Non-Current Assets at $241000.0 in Q1 2026, $6.1 million in Q4 2025, and $5.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn 11.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.62 Mn
Mar 31, 2026 5.72 Mn
Dec 31, 2025 6.11 Mn
Sep 30, 2025 5.34 Mn
Jun 30, 2025 5.37 Mn
Mar 31, 2025 5.55 Mn
Dec 31, 2024 4.90 Mn
Sep 30, 2024 5.05 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 4.58 Mn
Dec 31, 2023 4.59 Mn
Sep 30, 2023 241,000.00
Jun 30, 2023 241,000.00
Mar 31, 2023 241,000.00
Dec 31, 2022 241,000.00
Sep 30, 2022 241,000.00
Jun 30, 2022 241,000.00
Mar 31, 2022 241,000.00
Dec 31, 2021 241,000.00
Sep 30, 2021 241,000.00